🇺🇸 FDA
Pipeline program

BMN 165 (rAvPAL-PEG)

165-205

Phase 2 mab completed

Quick answer

BMN 165 (rAvPAL-PEG) for Phenylketonuria is a Phase 2 program (mab) at BioMarin International Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
BioMarin International Limited
Indication
Phenylketonuria
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials